Commencing in the early 2000s, the life sciences sector initiated a shift in the paradigm of clinical trials. Technological advancements, such as electronic data capture (EDC), played a pivotal role in laying the groundwork for the introduction of the initial electronic clinical trial systems. Subsequently, the industry witnessed pioneering developments like electronic clinical outcome assessments (eCOA) and electronic informed consent (eConsent), both introduced for the first time.
In 2011, Pfizer marked a significant milestone by embarking on the journey toward decentralization, notably conducting the industry's inaugural "virtual" clinical trial. Today, the integration of digital and decentralized components has become a standard practice in the realm of clinical drug development.
Thankfully, Clinical trial teams have the flexibility to choose the digital tools that best suit their specific trial needs. There's no requirement to adopt all of them simultaneously, nor is it necessary to use the same tools across different trials. These digital solutions provide both adaptability and user-friendliness, as they can seamlessly operate on smartphones, tablets, or any other device of your preference.
Obtain a complete understanding of the tools and services available for trial enrollment, screening, consent, and data collection by diving into this introductory handbook on decentralized clinical trials.